Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin.
Since microRNAs (miRNAs, miRs) have been implicated in oncogenesis, many of them have been identified as therapeutic targets. Previously we have demonstrated that miRNA-10b acts as a master regulator of the viability of metastatic tumor cells and represents a target for therapeutic intervention. We...
Main Authors: | Byunghee Yoo, Patricia Greninger, Giovanna T Stein, Regina K Egan, Joseph McClanaghan, Anna Moore, Cyril H Benes, Zdravka Medarova |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6054402?pdf=render |
Similar Items
-
Radiolabeling and PET–MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer
by: Mariane Le Fur, et al.
Published: (2021-07-01) -
MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancer
by: Byunghee Yoo, et al.
Published: (2021-02-01) -
Investigation of the Application of miR10b and miR135b in the Identification of Semen Stains.
by: Dayue Tong, et al.
Published: (2015-01-01) -
Guidelines for Rational Cancer Therapeutics
by: Byunghee Yoo, et al.
Published: (2017-12-01) -
New Directions in the Study and Treatment of Metastatic Cancer
by: Byunghee Yoo, et al.
Published: (2018-07-01)